Skip to main content
Midas Edge

HEALTHEQUITY INC

For the period ended Jan 31, 2024. Filed Mar 22, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 22, 2024

HQY$102.11-1.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Draper, State of Utah on this 22 nd day of March, 2024.

HEALTHEQUITY, INC.
Date: March 22, 2024By:/s/ Jon Kessler
Name:Jon Kessler
Title:President and Chief Executive Officer

-88-

Power of attorney

KNOW ALL PERSONS BY THESE PRESENT, that each person whose signature appears below hereby constitutes and appoints Jon Kessler and James Lucania, and each of them acting individually, as his or her true and lawful attorneys-in-fact and agents, with full power of each to act alone, with full powers of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, with full power of each to act alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her or their substitutes, may lawfully do or cause to be done by virtue hereof.

-89-

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Date: March 22, 2024By:/s/ Robert Selander
Name:Robert Selander
Title:Chairman of the Board, Director
Date: March 22, 2024By:/s/ Jon Kessler
Name:Jon Kessler
Title:President and Chief Executive Officer (Principal Executive Officer), Director
Date: March 22, 2024By:/s/ James Lucania
Name:James Lucania
Title:Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
Date: March 22, 2024By:/s/ Paul Black
Name:Paul Black
Title:Director
Date: March 22, 2024By:/s/ Frank Corvino
Name:Frank Corvino
Title:Director
Date: March 22, 2024By:/s/ Adrian Dillon
Name:Adrian Dillon
Title:Director
Date: March 22, 2024By:/s/ Evelyn Dilsaver
Name:Evelyn Dilsaver
Title:Director
Date: March 22, 2024By:/s/ Debra McCowan
Name:Debra McCowan
Title:Director
Date: March 22, 2024By:/s/ Rajesh Natarajan
Name:Rajesh Natarajan
Title:Director
Date: March 22, 2024By:/s/ Stephen Neeleman
Name:Stephen Neeleman, M.D.
Title:Vice Chairman and Director
Date: March 22, 2024By:/s/ Stuart Parker
Name:Stuart Parker
Title:Director
Date: March 22, 2024By:/s/ Gayle Wellborn
Name:Gayle Wellborn
Title:Director

-90-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.